What is the recommended hospital treatment protocol for an acute moderate-to-severe COPD exacerbation?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 2, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Ask Question

Hospital Treatment Protocol for Acute Moderate-to-Severe COPD Exacerbation

For patients hospitalized with acute moderate-to-severe COPD exacerbation, initiate nebulized bronchodilators (salbutamol 2.5-5 mg or terbutaline 5-10 mg plus ipratropium bromide 500 μg) every 4-6 hours, systemic corticosteroids (prednisolone 30 mg daily for 7-14 days), antibiotics if two or more cardinal symptoms are present (increased dyspnea, sputum volume, or purulence), controlled oxygen therapy targeting PaO2 >7.5 kPa (60 mmHg) or SpO2 >90%, and arterial blood gas monitoring within 60 minutes of admission. 1, 2, 1

Initial Assessment and Monitoring

Upon hospital admission, immediately obtain arterial blood gases to assess for hypercapnia and respiratory acidosis 1. A pH below 7.26 predicts poor outcomes and necessitates intensive monitoring 1. Repeat blood gas measurements within 60 minutes of starting oxygen therapy and after any change in inspired oxygen concentration 1.

Critical pitfall: In patients with known COPD aged ≥50 years, never exceed 28% FiO2 via Venturi mask or 2 L/min via nasal cannulae until arterial blood gases are known, as excessive oxygen can worsen hypercapnia and respiratory acidosis 1.

Bronchodilator Therapy

Immediate Treatment

  • Nebulized therapy on arrival: Administer salbutamol 2.5-5 mg OR terbutaline 5-10 mg OR ipratropium bromide 500 μg 1
  • For severe exacerbations or poor response: Combine both β-agonist (2.5-10 mg) with ipratropium bromide (250-500 μg) 3, 1
  • Frequency: Continue every 4-6 hours for 24-48 hours or until clinical improvement 3, 1

Important consideration: Drive nebulizers with compressed air (not oxygen) if PaCO2 is elevated or respiratory acidosis is present. Provide supplemental oxygen at 1-2 L/min via nasal prongs during nebulization to prevent desaturation 1.

Transition Strategy

Switch from nebulized to metered-dose inhaler or dry powder inhaler after 24-48 hours of clinical improvement, and observe for 24-48 hours before discharge 3, 1.

Systemic Corticosteroids

Standard regimen: Prednisolone 30-40 mg orally daily for 7-14 days 1, 2, 1. If oral route is not possible, use hydrocortisone 100 mg intravenously 1.

The evidence strongly supports systemic corticosteroids, which reduce treatment failure by 46% and shorten hospital stay by 1.4 days 4. However, discontinue after the acute episode (7-14 days maximum) unless there is documented benefit during clinical stability 1. Do not continue long-term corticosteroids beyond 30 days post-exacerbation 5.

Monitor for hyperglycemia, as the risk increases nearly 6-fold with systemic corticosteroid use 4.

Antibiotic Therapy

Indications

Prescribe antibiotics when two or more of the following cardinal symptoms are present 1:

  • Increased dyspnea
  • Increased sputum volume
  • Development of purulent sputum

Antibiotic Selection

First-line: Amoxicillin or tetracycline 1

Second-line (for severe exacerbations or first-line failure): Broad-spectrum cephalosporin, newer macrolides, or amoxicillin/clavulanate 1, 2, 1

Antibiotics reduce treatment failure by 46% and in-hospital mortality by 78% in hospitalized patients 4. Local bacterial resistance patterns should guide specific agent selection 2.

Oxygen Therapy Protocol

Target Parameters

  • PaO2 >7.5 kPa (60 mmHg) or SpO2 >90% 1, 2

Titration Strategy

  1. Start with low-flow oxygen (≤28% FiO2 or 2 L/min nasal cannulae) in patients with COPD history 1
  2. Check arterial blood gases within 60 minutes 1
  3. If PaO2 improves without pH deterioration, gradually increase inspired oxygen concentration 1
  4. Recheck blood gases within 60 minutes after each adjustment 1
  5. If pH falls due to rising PaCO2, consider non-invasive ventilation 1

Non-Invasive Ventilation (NIV)

Indications for NIV

Initiate NIV for patients with 2, 6, 4:

  • Respiratory acidosis (pH <7.35)
  • Hypercapnia with acute or acute-on-chronic respiratory failure
  • Persistent hypoxemia despite controlled oxygen therapy

NIV reduces intubation risk by 65%, in-hospital mortality by 55%, and hospital length of stay by 1.9 days, particularly in patients with respiratory acidosis 4. The 2017 ERS/ATS guideline strongly recommends NIV for hospitalized patients with acute or acute-on-chronic respiratory failure 6.

Timing is critical: Commence NIV early, before severe acidosis develops (pH <7.26), to avoid intubation and reduce mortality 7.

Adjunctive Therapies

Diuretics

Administer if peripheral edema and elevated jugular venous pressure are present 1.

Anticoagulation

Provide prophylactic subcutaneous heparin for venous thromboembolism prevention in patients with acute-on-chronic respiratory failure 1.

Intravenous Aminophylline

Consider only if patient fails to respond to nebulized bronchodilators: aminophylline 0.5 mg/kg/hour by continuous infusion with daily theophylline level monitoring 1. Evidence for effectiveness is limited 1.

Escalation Criteria

ICU/Special Care Unit Admission

Transfer to intensive or specialized respiratory care if 2:

  • Impending or actual respiratory failure
  • Other end-organ dysfunction (shock, renal, hepatic, neurological)
  • Hemodynamic instability
  • pH <7.26 despite initial therapy 1

Intubation Indications

Consider endotracheal intubation when 2:

  • Contraindications to NIV exist
  • Failure to improve on NIV
  • Severe respiratory acidosis with altered mental status
  • Inability to protect airway

Discharge Planning

Before discharge, ensure 3, 1:

  • Clinical improvement maintained for 24-48 hours on hand-held inhalers
  • Adequate home support available
  • Follow-up arranged with respiratory specialist or trained general practitioner
  • Smoking cessation counseling provided
  • Vaccination status reviewed (influenza, pneumococcal)
  • Consider early pulmonary rehabilitation referral 6

Post-discharge optimization: Reassess maintenance therapy to prevent future exacerbations, as even a single moderate exacerbation increases future risk 5.

References

7
Research

[Management of acute exacerbations of COPD].

Revue des maladies respiratoires, 2010

Related Questions

What is the recommended treatment for a severe chronic obstructive pulmonary disease (COPD) exacerbation?
What is the recommended management for a patient presenting with a COPD exacerbation in a Canadian OSCE clinical case, including oxygen targets, bronchodilator therapy, systemic corticosteroids, antibiotics, admission criteria, and discharge planning?
How should a mild COPD exacerbation presenting with increased dyspnea, cough, and sputum production without severe hypoxemia be managed?
In a patient with COPD acute exacerbation on continuous supplemental oxygen who has dyspnea on exertion, a dry non‑productive cough, and CT showing extensive mucus plugging without pulmonary embolus, should antibiotics be added to systemic corticosteroids and nebulized bronchodilator therapy?
A COPD patient who completed a course of oral steroids for an exacerbation now returns with a worsening green productive cough, fever, dyspnea, and oxygen saturation 97% on room air; what is the next best step in management?
For an HSV-positive mother whose newborn was treated at birth, how long should she continue pumping and discarding breast milk?
What is the appropriate dosing of vancomycin and piperacillin‑tazobactam (Zosyn) for a 44-year-old man with suspected osteomyelitis and foot cellulitis?
What percentage of patients with invasive ductal carcinoma stage IIB, Ki-67 approximately 1%, estrogen receptor positive and progesterone receptor positive, HER2-negative achieve remission after treatment?
What is an appropriate tapering schedule to discontinue duloxetine 90 mg daily?
What is the recommended antiviral and supportive treatment for influenza in adults and children, including dosing and considerations for high‑risk patients?
How should a newborn with a blister on or near the lip be evaluated and treated for possible neonatal herpes infection?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.